Project Grant R35GM164185
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $294,060 Project Grant to Princeton University beginning September 1, 2025, through August 31, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). The award supports fundamental research investigating emergent collective behavior in living systems across two distinct biological scales: bacterial quorum sensing in natural environments and phase separation mechanisms in...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Princeton University a Project Grant totaling $165,366.00 under the Biomedical Research and Research Training program (CFDA 93.859) effective May 1, 2026, through April 30, 2031. The award funds research to develop photoenzymes—biological catalysts that utilize photonic energy to drive chemical reactions—for selective chemical synthesis applications. The research project leverages naturally occurring...
- Federal Project Grant Award Summary Princeton University's Office of Research and Project Administration has been awarded $1,968,575 through the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) for a project titled "Computational Approaches for Elucidating Proteomes and Interactomes." The award, effective September 15, 2025, with completion scheduled for August 31, 2029, supports the development of advanced...
- Federal Grant Award Summary Princeton University's Office of Research and Project Administration received a $137,484 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective February 1, 2026 through January 31, 2028. The award supports research to uncover cryptic bacterial metabolites and their regulatory pathways by leveraging ecological interactions from algal and plant...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Princeton University $227,652 on June 26, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support a research project on stereoselective photoenzymatic transformations. The research, which will conclude on March 14, 2029, focuses on developing novel methods to synthesize chiral oxygen and nitrogen-containing heterocycles—compounds prevalent in pharmaceutical...
- Federal Project Grant Award Summary Yale University received a $2.01 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2026, through May 31, 2030. The award supports development of a synthetic biology platform using genomically recoded organisms (GROs) to engineer and study proteins with multiple posttranslational modifications (PTMs). The primary deliverable is an...
- Summary Princeton University received a $451,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through January 31, 2031. The award supports research focused on discovering and engineering new enzymes for amino acid and peptide modification. The project will develop biocatalytic tools and methods to identify, characterize, and engineer enzymes—particularly...
- Federal Project Grant Award Summary The National Institutes of Health (NIH) Office of the Director awarded a $1.476 million Project Grant (CFDA 93.310: Trans-NIH Research Support) to Princeton University on September 9, 2025, with completion anticipated by August 31, 2028. This award supports the development of novel artificial intelligence and machine learning methods to advance biomolecular structure determination at the proteome scale. The research addresses critical limitations in...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) under its Biomedical Research and Research Training program (CFDA 93.859) awarded a Project Grant of $607,689 to The Trustees of Columbia University in the City of New York, effective July 15, 2025, with a completion date of April 30, 2030. The research initiative, titled "Mechanism-Informed Design of Allosteric Protein Sensors," focuses on developing computational and experimental methods to...
- FEDERAL PROJECT GRANT AWARD SUMMARY Princeton University received a $1.0 million Project Grant from the National Science Foundation (NSF) Division of Molecular and Cellular Biosciences under the Biological Sciences program (CFDA 47.074), effective August 1, 2025 through July 31, 2029. The award funds fundamental research on quorum sensing—a bacterial cell-to-cell communication process that enables bacterial populations to synchronize behavior based on population density and species...
Princeton University's Office of Research and Project Administration received a $369,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2026, through May 31, 2031. The Toettcher Laboratory will develop and advance innovative synthetic biology tools—including biosensors, optogenetics systems, and synthetic gene circuits—to measure and manipulate intracellular signaling pathways and understand how these pathways control critical cellular processes such as gene expression, cell differentiation, and tissue movement. Over the five-year period, the research will deliver next-generation optogenetic tools and biosensors with applications spanning developmental biology and cellular signaling research. Specifically, the project will apply these tools to investigate developmental pattern robustness in Drosophila embryos, elucidate receptor tyrosine kinase feedback regulation, and conduct screens to identify regulators of ERK (extracellular signal-regulated kinase) signaling dynamics relevant to tissue movement and wound healing. The deliverables include light-switchable and kinase-controlled proteins for cellular control, along with fundamental insights into how cells interpret developmental signals and regulate signaling dynamics—research outcomes expected to have broad application across biomedical science.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $369.0k | 5/26/26 |